Time course of organ failure in patients with septic shock treated with hydrocortisone: Results of the Corticus study

Intensive Care Medicine

Volumn 37, Issue 11, 2011, Pages 1765-1772

  Moreno, R ^a   Sprung, C L ^b   Annane, D ^c   Chevret, S ^d   Briegel, J ^e   Keh, D ^f   Singer, M ^g   Weiss, Y G ^b   Payen, D ^h   Cuthbertson, B H ⁱ   Vincent, J L ^j  

^a HOSPITAL DE SANTO ANTÓNIO DOS CAPUCHOS   (Portugal)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^c RAYMOND POINCARÉ HOSPITAL   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^f CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^g UNIVERSITY COLLEGE LONDON   (United Kingdom)

^h HÔPITAL LARIBOISIÈRE   (France)

ⁱ SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^j ERASME HOSPITAL   (Belgium)

more..

Author keywords

Corticosteroids; Hydrocortisone; Mortality; Organ dysfunction; Organ failure; Septic shock; Sequential Organ Failure Assessment score. SOFA; Steroids

Indexed keywords

HYDROCORTISONE; PLACEBO;

ADULT; ARTICLE; BLOOD CLOTTING DISORDER; CARDIOVASCULAR DISEASE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG MEGADOSE; HUMAN; KIDNEY FAILURE; LIVER FAILURE; MAJOR CLINICAL STUDY; MORBIDITY; MORTALITY; MULTICENTER STUDY; MULTIPLE ORGAN FAILURE; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY FAILURE; SEPTIC SHOCK; TREATMENT DURATION; TREATMENT RESPONSE;

ADOLESCENT; ADULT; ANTI-INFLAMMATORY AGENTS; DOUBLE-BLIND METHOD; EUROPE; HOSPITAL MORTALITY; HUMANS; HYDROCORTISONE; INTENSIVE CARE UNITS; MIDDLE AGED; MULTIPLE ORGAN FAILURE; OUTCOME ASSESSMENT (HEALTH CARE); PROSPECTIVE STUDIES; SHOCK, SEPTIC; TIME FACTORS; YOUNG ADULT;

EID: 82555165000     PISSN: 03424642     EISSN: 14321238     Source Type: Journal    
DOI: 10.1007/s00134-011-2334-x     Document Type: Article

References (23)

1. AJ Petros JC Marshall HK van-Saene 1995 Should morbidity replace mortality as an endpoint for clinical trials in intensive care? Lancet 345 369 371 7772121 10.1016/S0140-6736(95)90347-X 1:STN:280:DyaK2M7kslGqtg%3D%3D
2. Knaus WA, Wagner DP, Harrell FE, Draper EA (1994) What determines prognosis in sepsis? Evidence for a comprehensive individual patient risk assessment approach to the design and analysis of clinical trials. In: Reinhart K, Eyrich K, Sprung C (eds) Sepsis current perspectives in pathophysiology and therapy. Springer-Verlag, Berlin Heidelberg, pp 23-37
3. J-R Le Gall S Lemeshow G Leleu J Klar J Huillard M Rué D Teres A Artigas 1995 Customized probability models for early severe sepsis in adult intensive care patients JAMA 273 644 650 7844875 10.1001/jama.273.8.644 1:STN:280:DyaK2M7kslegsA%3D%3D
4. GR Bernard J-L Vincent P-F Laterre SP LaRosa J-F Dhainaut A Lopez-Rodriguez JS Steingrub GE Garber JD Helterbrand EW Ely CD Fisher Jr for the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group 2001 Efficacy and safety of recombinant human activated protein C for severe sepsis N Engl J Med 344 699 709 11236773 10.1056/NEJM200103083441001 1:CAS:528:DC%2BD3MXitFamt7s%3D (Pubitemid 32204987)
5. J-L Vincent DC Angus A Artigas A Kalil BR Basson HH Jamal G Johnson III GR Bernard for the Recombinant Human Activated Protein C Worldwide Evaluation in Severe Sepsis (PROWESS) Study Group 2003 Effects of drotrecogin alfa (activated) on organ dysfunction in the PROWESS trial Crit Care Med 31 834 840 12626993 10.1097/01.CCM.0000051515.56179.E1 1:CAS:528:DC%2BD3sXhvVyrtro%3D (Pubitemid 36379592)
6. J Carlet 2006 Prescribing indications based on successful clinical trials in sepsis: a difficult exercise Crit Care Med 34 525 529 16424736 10.1097/01.CCM.0000198329.85851.8E 1:STN:280:DC%2BD28%2FjsFKmsg%3D%3D (Pubitemid 43145633)
7. JC Marshall JL Vincent G Guyatt DC Angus E Abraham G Bernard C Bombardier T Calandra HS Jørgensen R Sylvester M Boers 2005 Outcome measures for clinical research in sepsis: A report of the 2nd Cambridge Colloquium of the international sepsis forum Crit Care Med 33 1708 1716 16096445 10.1097/01.CCM.0000174478.70338.03 (Pubitemid 41153694)
8. The Acute Respiratory Distress Syndrome Network 2000 Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome N Engl J Med 342 1301 1308 10.1056/NEJM200005043421801 (Pubitemid 30408714)
9. HE Lilja A Leppäniemi E Kemppainen 2008 Utilization of intensive care unit resources in severe acute pancreatitis JOP 8 179 184 (Pubitemid 351611731)
10. CL Sprung D Annane D Keh R Moreno M Singer K Freivogel YG Weiss J Benbenishty A Kalenka H Forst P-F Laterre K Reinhart BH Cuthbertson D Payen J Briegel for the CORTICUS Study Group 2008 Hydrocortisone Therapy for Patients with Septic Shock N Engl J Med 358 111 124 18184957 10.1056/NEJMoa071366 1:CAS:528:DC%2BD1cXltFWltw%3D%3D
11. JR Le Gall S Lemeshow F Saulnier 1993 A new simplified acute physiology score (SAPS II) based on a European/North American multicenter study JAMA 270 2957 2963 8254858 10.1001/jama.270.24.2957 1:STN:280:DyaK2c%2Fns1GmtA%3D%3D (Pubitemid 24000804)
12. J-L Vincent R Moreno J Takala S Willats A De Mendonça H Bruining CK Reinhart PM Suter LG Thijs 1996 The SOFA (Sepsis-related organ failure assessment) score to describe organ dysfunction/failure Intensive Care Med 22 707 710 8844239 10.1007/BF01709751 1:STN:280:DyaK2s%2FgtFantQ%3D%3D (Pubitemid 26254283)
13. R Moreno J-L Vincent R Matos A Mendonça F Cantraine L Thijs J Takala C Sprung M Antonelli H Bruining S Willatts on behalf of the Working Group on "Sepsis-related problems" of the European Society of Intensive Care Medicine 1999 The use of maximum SOFA score to quantify organ dysfunction/failure in intensive care. Results of a prospective, multicentre study Intensive Care Med 25 686 696 10470572 10.1007/s001340050931 1:STN:280:DyaK1MzpvFGqsQ%3D%3D (Pubitemid 29376122)
14. NM Laird JH Ware 1982 Random-effects models for longitudinal data Biometrics 38 4 963 974 7168798 10.2307/2529876 1:STN:280:DyaL3s7nvFWlsg%3D%3D
15. SH Lipsitz K Kim L Zhao 1994 Analysis of repeated categorical data using generalized estimating equations Stat Med 13 1149 1163 8091041 10.1002/sim.4780131106 1:STN:280:DyaK2cznslOqsg%3D%3D (Pubitemid 24191583)
16. J Briegel H Forst M Haller G Schelling E Kilger G JKuprat B Hemmer A Lenhart M Heyduck C Stoll K Peter 1999 Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single-center study Crit Care Med 27 723 732 10321661 10.1097/00003246- 199904000-00025 1:STN:280:DyaK1M3ltlGkug%3D%3D (Pubitemid 29218204)
17. D Annane V Sébille C Charpentier PE Bollaert B François J-M Korach G Capellier Y Cohen E Azoulay G Troché P Chaumet-Riffaut E Bellissant 2002 Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock JAMA 288 862 871 12186604 10.1001/jama.288.7.862 1:CAS:528:DC%2BD38Xmt1yitL4%3D
18. PE Bollaert 2000 Stress doses of glucocorticoids in catecholamine dependency: a new therapy for a new syndrome? Intensive Care Med 26 3 5 10663271 10.1007/s001340050002 1:STN:280:DC%2BD3c7jtVaiuw%3D%3D (Pubitemid 30184452)
19. D Keh T Boehnke S Weber-Cartens C Schulz O Ahlers S Bercker H-D Volk W-D Doecke KJ Falke H Gerlach 2003 Immunologic and hemodynamic effects of "Low-Dose" hydrocortisone in septic shock. A double-blind, randomized, placebo-controlled, crossover study Am J Respir Crit Care Med 167 512 520 12426230 10.1164/rccm.200205-446OC
20. T Saito M Takanashi E Gallagher A Fuse S Suzaki O Inagaki K Yamada R Ogawa 1995 Corticosteroid effect on early beta-adrenergic down-regulation during circulatory shock: hemodynamic study and beta-adrenergic receptor assay Intensive Care Med 21 204 210 7790605 10.1007/BF01701473 1:STN:280: DyaK2MzhtVKitg%3D%3D
21. PC Minneci KJ Deans SM Banks PQ Eichacker C Natanson 2004 Meta-Analysis: the effect of steroids on survival and shock during sepsis depends on the dose Ann Intern Med 141 47 56 15238370 1:CAS:528:DC%2BD2cXmtVKqurw%3D
22. Y Hayashi T Takayama S Yamazaki M Moriguchi T Ohkubo H Nakayama T Higaki 2011 Validation of perioperative steroids administration in liver resection: a randomized controlled trial Ann Surg 253 50 55 21233606 10.1097/SLA. 0b013e318204b6bb
23. RP Dellinger MM Levy JM Carlet J Bion MM Parker R Jaeschke K Reinhart DC Angus C Brun-Buisson R Beale T Calandra J-F Dhainaut H Gerlach M Harvey JJ Marini J Marshall M Ranieri G Ramsay J Sevransky BT Thompson S Townsend JS Vender JL Zimmerman J-L Vincent 2008 Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2008 Intensive Care Med 34 17 60 18058085 10.1007/s00134-007-0934-2